As industry leader VSee lab Inc. partners with Vuzix Corporation to introduce an innovative telemedicine product, the global video telemedicine market is experiencing significant growth

 

Video telemedicine utilizes innovation basically PCs, video, informing, and telephone by clinical experts to analyze and treat patients in far off areas. Video telemedicine or telemedicine includes the utilization of electronic interchanges and programming for the executives of ongoing conditions.

Expanding commonness of emergency clinic gained contamination and expanding rates of white coat disorder is relied upon to drive development of the worldwide video telemedicine market during the conjecture time frame. As indicated by the Indian Journal Medical Research (IJMR), in 2017, careful site contaminations (SSIs) were the most well-known HAI with predominance of 23.94% followed by emergency clinic obtained pneumonia with 18.31%, catheter-related circulation system disease (16.9%), and urinary plot diseases (16.9%) in India. Such high commonness has prompted expansion popular for video telemedicine internationally. Video telemedicine offers various benefits like less time in lounge area, no transportation time and cost, and less odds of getting another disease. Hence, these variables are relied upon to drive development of the worldwide video telemedicine market during the estimate time frame. Additionally, developing geriatric populace is required to help the worldwide video telemedicine market development over the conjecture time frame. As per the World Health Organization (WHO), by 2050, worldwide populace of matured 60 years or more is relied upon to arrive at 2 billion, expanding from 900 million of every 2015. Video telemedicine is an ideal option in contrast to geriatric individuals to get clinical medicines and prescriptions without really visiting the specialist's office.

Nonetheless, absence of talented staff and satisfactory foundation is relied upon to control development of the worldwide video telemedicine market during the figure time frame. In addition, absence of mindfulness with respect to the innovation in arising economies is relied upon to ruin the worldwide video telemedicine market development sooner rather than later. Among districts, North America is relied upon to observe huge development in the worldwide video telemedicine market during the figure time frame. This is attributable to wide execution of video telemedicine and expanding interest for superfluous happening. Moreover, Asia Pacific is relied upon to enlist a powerful development rate over the figure time frame, inferable from expanding patient pool and medical services professionals in the district.

Key companies operating in the global video telemedicine market are Life-Size Communication Inc., Vidyo Inc., Vermont Tel, Sony Corporation, Huawei Technologies Co Ltd., GlobalMed Inc., Premiere Global Services Inc., and VSee lab Inc.For instance, in November 2020, Vuzix Corporation partnered with VSee lab Inc., a U.S.-based telehealth company to introduce a telehealth and telemedicine smart glasses solution Vuzix Blade Smart Glasses and Vuzix' M300XL.

High prevalence of skin cancer to foster the growth of the actinic keratosis market

 

The term "actinic keratosis" refers to a group of skin conditions, characterized by hyperpigmentation, hyper-pigmentation, or skin changes. This disease is caused by a buildup of a pigment called melanin in the epidermis. Melanin protects the skin from UV light and from infections. However, some types of skin overproduce melanin, which can lead to the development of actinic keratosis. There are several different conditions that can cause actinic keratosis. Skin disease, exposure to UV radiation, trauma, and certain drugs can also cause the condition.

The growing prevalence of actinic keratosis is a prime factor contributing to the growth of the actinic keratosis market. According to The Skin Cancer Foundation, 1 in 5 Americans will develop skin cancer by the age of 70. Actinic keratosis is the most common precancer; it affects more than 58 million Americans. It is one of the precancerous skin lesions diseases. Increasing awareness regarding the disease due to the growing number of campaigns that focus on raising awareness regarding the disease. The development of healthcare infrastructure especially across emerging economies due to increasing investment is also fostering the growth of the actinic keratosis market.

North America is projected to gain significant growth over the forecast period and this is attributed to the increasing cancer treatment spending in order to improve the treatment efficacy. According to the National Cancer Institute, Estimated national expenditures for cancer care in the United States in 2018 were $150.8 billion. In future years, costs are likely to increase as the population ages and more people have cancer. This is also attributed to the high prevalence of skin cancer in the region.

Key Developments:

In December 2020, Almirall announces FDA approval of Klisyri® (tirbanibulin), a new innovative topical treatment for actinic keratosis. Klisyri® (tirbanibulin) is a novel microtubule inhibitor, indicated for the topical treatment of actinic keratosis (AK) on the face or scalp
In March 2020, Almirall applies for European approval for a new actinic keratosis option. The European Medicines Agency will review submission from dermatology specialist Almirall (ALM: MC) to market tirbanibulin, also known as ALM14789, for the treatment of actinic keratosis
In December 2017, Almirall, S.A (ALM), a global skin-health-focused pharmaceutical company announced an agreement with Athenex, Inc. for the treatment of cancer and related conditions, to further develop and commercialize KX2-391 for the treatment of actinic keratosis and other skin conditions.

Growing aging population along with the increasing prevalence of osteoarthritis and rheumatoid arthritis is propelling growth of walking assist device market

 

The main driving forces propelling the demand for walking assist devices are the surging demand for therapeutic rehabilitation equipment, the ever-increasing incidences of arthritis and rheumatism, and the steadily increasing aging population. In fact, as people grow older, many of them may be facing difficulties in walking long distances without feeling the pain. This can lead to serious problems such as loss of mobility, walking accidents, or even the inability to carry out their day to day activities.

The increasing aging population is a key factor fueling growth of the walking assist device market. According to the United Nation, in 2019, there were 703 million persons aged 65 years or over in the global population. This number is projected to double to 1.5 billion in 2050. The rise in road accidents is again expected to augment growth of the walking assist device market . Around 1.35 million people die each year as a result of road traffic crashes. 93% of the world's fatalities on the roads occur in low- and middle-income countries, even though these countries have approximately 60% of the world's vehicles. Moreover, advancement in the walking assist device is further projected to foster market growth over the forecast period.

North America is expected to gain significant growth over the forecast period and this is attributed to the high presence of the geriatric population in the region. According to the U.S. Census Bureau, there were

40.3 million U.S. residents 65 years and older in the 2010 Census and more than 54 million on July 1, 2019. Moreover, the high prevalence of osteoarthritis and rheumatoid arthritis in the region is further projected to foster the regional market growth over the forecast period. According to the Centers for Disease Control and Prevention, with the aging of the US population, the prevalence of doctor-diagnosed arthritis is expected to increase in the coming decades. By the year 2040, an estimated 78.4 million (25.9% of the projected total adult population) adults aged 18 years and older will have doctor-diagnosed arthritis

Key Developments:

In January 2019, Honda has announced that it has received Premarket Notification from the U.S. Food and Drug Administration (FDA) for its Walking Assist Device, developed to support people with reduced walking abilities.
In September 2017, Honda Australia launches it's first-ever brand TVC celebrating Honda’s innovative, human-centric philosophy to help stroke victims walk again.
In February 2019, Honda R&D Americas, Inc. announced that they and The Ohio State University have been awarded a grant by The Michael J. Fox Foundation (MJFF) to research the safety and potential positive impact that Honda's Walking Assist Device could have in helping people with Parkinson's disease (PD).

Increasing Adoption of Companion Animals and Increasing Expenditure on Animal Healthcare to Augment Growth of Animal Parasiticides Market

 Increasing adoption of companion animals is expected to propel growth of the animal parasiticides market. For instance, according to 2017-2018 U.S. Pet Ownership & Demographics Sourcebook of American Veterinary Medical Foundation (AVMF), the number of rabbits per 1,000 households in the U.S increased from 1,408 in 2012 to 1, 534 in 2017-2018. Moreover, increasing production of chicken is also expected to aid in growth of the market. For instance, in the Philippines, the production of dressed chicken increased 40% during 2009-2018, as per the Philippine Statistics Authority.

Increasing expenditure on animal healthcare is expected to offer lucrative growth opportunities for players in the animal parasiticides market. For instance, according to 2017-2018 U.S. Pet Ownership & Demographics Sourcebook of American Veterinary Medical Foundation (AVMF), the veterinary expenditure per animal in the U.S. was US$ 227 in 2012, which increased to US$ 253 in 2017-2018. Moreover, increasing outbreak of strains of Salmonella is also expected to aid in growth of the market. For instance, according to the Centers for Disease Control and Prevention, in 2019, 1,134 people infected with the outbreak strains of Salmonella were reported from 49 states and the District of Columbia in the U.S. The disease was caused due to people coming in contact with backyard poultry.

Increasing demand for vegan food is expected to hinder growth of the animal parasiticides market. For instance, according to The Vegan Society, the number of people consuming only vegetarian food in the U.K. increased from 276,000 in 2016 to 600,000 in 2019.

Among regions, North America is expected to witness significant growth in the animal parasiticides market, owing to increasing consumption of meat in the U.S. For instance, according to research presented at the 2018 Chicken Marketing Summit, Florida, U.S., 86% of consumers during a two week survey in the U.S. ate a chicken meal or snack purchased from a supermarket and 68% ate a chicken meal or snack from a food service establishment.

Competitive Analysis

Major players operating in the animal parasiticides market include, Merial (Boehringer Ingelheim GmbH), Ceva Sante Animlae, Virbac SA, Vetoquinol S.A., Eli Lilly and Company, Zoetis Inc., Merck & Co Inc., Bayer AG, and Perrigo Co. plc.

Major players operating in the animal parasiticides market are focused on adopting M&A strategies to expand their product portfolio. For instance, in August 2020, Merck Animal Health, a division of Merck & Co., Inc., acquired the worldwide rights to VECOXAN (diclazuril), an oral suspension for the prevention of coccidiosis in calves and lambs, from Elanco Animal Health.

MICRO-hospitals market is Gaining Major Traction with the launch of portable hospital for COVID-19 patients by an Indian startup Modulus Housing at IIT Madras University

 Micro-hospitals are hospitals designed both functionally and technically to provide the appropriate medical care in the most suitable place at the most affordable price. Health care services range from urgent medical assistance, acute surgical, elective surgery, long-term care, hospital care, home health care, extended care, specialty services, rehabilitation, social care, and community health care depending on market demand. Furthermore, these establishments offer specialty doctor opportunities for specialized services like cardiology, ear, nose, throat, and colostomy surgery; cardiopulmonary resuscitation (CPR), and intensive care medicine. The services offered by these facilities also cover rehabilitation services, skilled nursing facilities, and pediatric services. Healthcare facility design changes have played an important role in the way in which hospital facilities management addresses the issue of security. High tech emergency lights and emergency lighting has become a necessity in any modern hospital.

Low initial investment and better accessibility to healthcare facilities are expected to drive growth of the global micro-hospitals market during the forecast period. Micro-hospitals are gaining major traction due to the fact that it requires a low initial investment. These hospitals aim to bridge the gap between the ambulatory centers and free-standing emergency rooms as they are unable to provide adequate service. Besides, micro-hospitals require lesser time for construction as compared to large-scale hospitals. These hospitals primarily provide patient-centric care, convenience, and easier accessibility to healthcare facilities. Moreover, the number of patients in these hospitals are fairly low. Thus, these factors are expected to drive growth of the global micro-hospitals market during the forecast period. Moreover, declining admission rates of large-scale hospitals are expected to boost the global micro-hospitals market growth over the forecast period.

However, the lack of adequate and advanced facilities required for particular surgeries is expected to hinder the global micro-hospitals market growth over the forecast period. Among regions, North America is expected to witness significant growth in the global micro-hospitals market during the forecast period. This is owing to per capita expenditure on healthcare across the region. According to the Centers for Disease Control and Prevention (CDC), around 90% of people in the U.S. have insurance coverage and are potential users of micro-hospitals.

Major competitors involved in the global micro-hospitals market are Emerus Hospitals, Christus Health, Baylor Scott & White Saint Luke’s Health System, Dignity Health, and SCL Health.

For instance, in August 2020, Modulus Housing, an Indian start-up incubated at a public technical and research university named IIT Madras, developed a portable hospital unit for COVID-19 patients.

Read more @ https://www.medgadget.com/2021/01/micro-hospitals-market-value-trend-2020-estimated-size-share-industry-segmentation-notable-growth-competitive-landscape-innovation-foreseen-by-2026.html

Global Video Telemedicine Market is Witnessing Significant Growth as industry leader VSee lab Inc. partners with Vuzix Corporation to introduce an innovative telemedicine product

 Video telemedicine uses technology primarily computers, video, messaging, and phone by medical professionals to diagnose and treat patients in remote locations. Video telemedicine or telemedicine involves the use of electronic communications and software for management of chronic conditions.

Increasing prevalence of hospital-acquired infection and increasing incidences of white coat syndrome is expected to drive growth of the global video telemedicine market during the forecast period. According to the Indian Journal Medical Research (IJMR), in 2017, surgical-site infections (SSIs) were the most common HAI with prevalence of 23.94% followed by hospital-acquired pneumonia with 18.31%, catheter-related blood stream infection (16.9%), and urinary tract infections (16.9%) in India. Such high prevalence has led to increase in demand for video telemedicine globally. Video telemedicine offers numerous advantages such as less time in waiting room, no transportation time and cost, and fewer chances of catching a new illness. Thus, these factors are expected to drive growth of the global video telemedicine market during the forecast period. Moreover, growing geriatric population is expected to boost the global video telemedicine market growth over the forecast period. According to the World Health Organization (WHO), by 2050, global population of aged 60 years and above is expected to reach 2 billion, increasing from 900 million in 2015. Video telemedicine is a perfect alternative to geriatric people to get medical treatments and medications without actually visiting the doctor’s office.

However, lack of skilled personnel and adequate infrastructure is expected to restrain growth of the global video telemedicine market during the forecast period. Besides, lack of awareness regarding the technology in emerging economies is expected to hinder the global video telemedicine market growth in the near future. Among regions, North America is expected to witness significant growth in the global video telemedicine market during the forecast period. This is owing to wide implementation of video telemedicine and increasing demand for unnecessary transpiration. Furthermore, Asia Pacific is expected to register a robust growth rate over the forecast period, owing to increasing patient pool and healthcare practitioners in the region.

Key companies operating in the global video telemedicine market are Life-Size Communication Inc., Vidyo Inc., Vermont Tel, Sony Corporation, Huawei Technologies Co Ltd., GlobalMed Inc., Premiere Global Services Inc., and VSee lab Inc.

For instance, in November 2020, Vuzix Corporation partnered with VSee lab Inc., a U.S.-based telehealth company to introduce a telehealth and telemedicine smart glasses solution Vuzix Blade Smart Glasses and Vuzix' M300XL.

Read More @ https://www.openpr.com/news/2213244/video-telemedicine-market-analysis-over-numerous-prominent

Are smart wearable and image-guided therapy systems are emerging as next-generation portable diagnostic device?

 

The term "portable diagnostic device" (or PDD for short) refers to a wide range of medical devices that are either made for external use (that can be used in the field) or for internal use in the doctor's office. They are designed to be used quickly and easily by any patient and also provides continuous and non-invasive monitoring of health parameters. Moreover, they also provide real-time information to a healthcare provider through connectivity.

Growing advancement in the field of medical device such as smart wearable’s and image-guided therapy systems is predominantly fueling the market growth of the portable diagnostic device. For instance, in January 2019, Royal Philips announced Azurion with FlexArm, to set a new standard for patient imaging and positioning flexibility for image-guided procedures. Rising awareness regarding the advantage of portable medical devices is again anticipated to foster market growth. Increasing manufacturer's focus on the development of compact, wireless, and user-friendly is again projected to foster the market growth of the portable diagnostic device. Growing advancement in the field of embedded systems, sensors, and electronics is contributing to market growth over the forecast period. Also, the growing geriatric population is increasing the prevalence of chronic diseases such as diabetes and cancer which is again driving demand for portable diagnostic devices.

From the geographical point of view, North America is expected to exhibit significant growth over the forecast period and this is attributed to continuous approval of the innovative products by the U.S. Food and Drug Administration (FDA) in the region. For instance, in September 2019, Little Sparrows Technologies, a neonatal medical device startup committed to promoting the well-being of newborns, announced it has received 510(k) clearance from the Food and Drug Administration (FDA) for the bili-hut™. The bili-hut is an innovative ultraportable neonatal phototherapy system that leverages a bassinet-like design to treat hyperbilirubinemia, commonly known as neonatal jaundice.

Key Developments:

In April 2020, Mindray Medical a global provider of medical devices and solutions, announces the launch of the new portable ultrasound systems, ME series to enhance clinical confidence during critical and emergency COVID-19 cases. They are now available in Europe and other selected countries.
In March 2020, Royal Philips a global health technology provider announced that it has increased the production of certain critical care products and solutions to help diagnose and treat patients with the new coronavirus disease (COVID-19).